You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren’s disease

Article info

Article menu

Download PDFPDF

Sjögren syndrome
Original research
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren’s disease

Authors

  • Renaud Felten Service de Rhumatologie - Centre National de Référence des maladies auto-immuneset et auto-inflammatoires systémiques rares RESO, Hopitaux universitaires de Strasbourg, Strasbourg, FranceImmunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France PubMed articlesGoogle scholar articles
  • Anne-Perrine Foray Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France PubMed articlesGoogle scholar articles
  • Pascal Schneider Department of Immunobiology, University of Lausanne, Lausanne, Switzerland PubMed articlesGoogle scholar articles
  • Cindy Marquet Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France PubMed articlesGoogle scholar articles
  • Coralie Pecquet Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France PubMed articlesGoogle scholar articles
  • Fanny Monneaux Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France PubMed articlesGoogle scholar articles
  • Hélène Dumortier Immunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France PubMed articlesGoogle scholar articles
  • Jean Sibilia Service de Rhumatologie - Centre National de Référence des maladies auto-immuneset et auto-inflammatoires systémiques rares RESO, Hopitaux universitaires de Strasbourg, Strasbourg, France PubMed articlesGoogle scholar articles
  • Fabrice Valette Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France PubMed articlesGoogle scholar articles
  • Lucienne Chatenoud Université Paris Cité, CNRS UMR 8253, INSERM UMR 1151, Institut Necker Enfants Malades-INEM, Paris, France PubMed articlesGoogle scholar articles
  • Jacques-Eric Gottenberg Service de Rhumatologie - Centre National de Référence des maladies auto-immuneset et auto-inflammatoires systémiques rares RESO, Hopitaux universitaires de Strasbourg, Strasbourg, FranceImmunologie, Immunopathologie et Chimie Thérapeutique, CNRS UPR 3572, IBMC, Strasbourg, France PubMed articlesGoogle scholar articles
  1. Correspondence to Pr Jacques-Eric Gottenberg; jacques-eric.gottenberg{at}chru-strasbourg.fr
View Full Text

Citation

Felten R, Foray A, Schneider P, et al
Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren’s disease
RMD Open 2024;10:e004112. doi: 10.1136/rmdopen-2024-004112

Publication history

  • Received January 12, 2024
  • Accepted July 19, 2024
  • First published August 28, 2024.
Online issue publication 
August 28, 2024

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.